The prognostic value of physical functioning on survival in patients with nonsmall cell lung cancer: a systematic review and meta-analysis.

Eur Respir RevOct 21, 2026 (epub)

Eva Arents, Sarah Haesevoets, Marthe Van Overbeke et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis examined whether objectively measured physical functioning predicts survival in adults with nonsmall cell lung cancer (NSCLC), across surgical and nonsurgical treatment groups. It included 58 studies involving 19 436 patients, with most assessments made before treatment. In nonsurgical cohorts, low functional exercise capacity was associated with higher mortality (HR 2.11); low handgrip strength and physical inactivity were also associated with higher mortality. Among surgical patients, survivors had higher exercise capacity (standardised mean difference 0.79).

Key findings

  • In nonsurgical cohorts, low functional exercise capacity was associated with higher mortality (HR 2.11).
  • Low handgrip strength (HR 1.27) and physical inactivity (HR 2.86) were associated with higher mortality in nonsurgical cohorts.
  • In the surgical-group meta-analysis, survivors had higher exercise capacity (standardised mean difference 0.79).
  • Surgical cohorts had no studies assessing physical functioning in the ICF domains of body functions and structures or participation.

Why it matters

The findings suggest that objective measures of physical functioning may add prognostic information across NSCLC treatment settings. Such measures could help characterise survival risk, although the evidence varies by treatment group and functional domain. The review also highlights gaps in surgical cohorts and the need for more consistent measurement before these indicators can be applied uniformly.

What to keep in mind

Studies showed heterogeneity and used varying thresholds. In surgical cohorts, evidence was limited to activity-based measures; body functions and participation were not evaluated.

Source

Published in Eur Respir Rev. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.